Biobot Analytics provides population-level health intelligence using wastewater data to support decision-making for pharmaceutical and life sciences, healthcare systems, and government agencies. The platform offers real-time insights into viral, bacterial, and chemical trends from wastewater, enabling outbreak surveillance, clinical trial support, and biodefense applications across national and local scales. Based globally, Biobot emphasizes privacy-first data and actionable intelligence to inform public health and policy decisions.
No recent news for this company.
No recent deals for this company.